The Impact of High Circulating Anti-Müllerian Hormone on Endometrial Thickness and Outcome of Assisted Reproductive Technology in Women with Polycystic Ovarian Syndrome: A Cohort Study.

Autor: Mohamed AA; Department of Obstetrics and Gynaecology, Assiut University, Assiut, Egypt., Al-Hussaini TK; Department of Obstetrics and Gynaecology, Assiut University, Assiut, Egypt., Hussein RS; Department of Obstetrics and Gynaecology, Assiut University, Assiut, Egypt., Abdallah KS; Department of Obstetrics and Gynaecology, Assiut University, Assiut, Egypt., Amer SA; Department of Obstetrics and Gynaecology, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby, UK.
Jazyk: angličtina
Zdroj: Journal of human reproductive sciences [J Hum Reprod Sci] 2022 Oct-Dec; Vol. 15 (4), pp. 370-376. Date of Electronic Publication: 2022 Dec 30.
DOI: 10.4103/jhrs.jhrs_112_22
Abstrakt: Background: Elevated circulating anti-Müllerian hormone (AMH) in women with the polycystic ovarian syndrome (PCOS) has been found to have a detrimental effect on endometrial function. This may adversely affect the outcome of in vitro fertilisation (IVF) in PCOS women.
Aims: To investigate the impact of high serum AMH concentrations on endometrial thickness (ET) and the outcome of IVF in women with PCOS.
Settings and Design: This retrospective cohort study included all PCOS women who underwent fresh IVF\intracytoplasmic sperm injection cycles between January 2016 and December 2021 in one major IVF centre.
Materials and Methods: PCOS diagnosis was based on Rotterdam criteria, and participants were identified from centre database. All women received antagonist protocol. Primary outcomes were trigger-day ET and live birth rate (LBR). Circulating AMH was correlated with ET and ovarian response.
Statistical Analysis Used: AMH levels were compared between women with and without live birth. ET and LBRs were compared between women with AMH <7.0 ng/ml versus those with AMH ≥7.0 ng/ml.
Results: The study included 102 PCOS women, of which six were excluded due to poor response ( n = 4), hyperresponse ( n = 1) or fertilisation failure ( n = 1). Of the remaining 96 women, 42 (43.8%) achieved a live birth. There was no statistically significant ( P > 0.05) correlation between AMH and ET. Mean ± standard deviation AMH concentration was not significantly ( P > 0.05) different between women with live birth (6.5 ± 3.4 ng/ml) and those without (6.5 ± 2.4 ng/ml). High AMH positively correlated with the number of oocytes retrieved, metaphase II oocytes and embryos ( P = 0.003, 0.006 and 0.006, respectively). There was no statistically significant ( P > 0.05) difference in ET or LBR between women with AMH <7.0 ng/ml ( n = 72; ET, 10.7 ± 1.8 mm; LBR, 45.8% [33/72] versus those with AMH ≥7.0 ng/ml ( n = 24; ET, 10.8 ± 1.7 mm; LBR, 37.5% [9/24]).
Conclusions: High circulating AMH in PCOS women does not seem to negatively affect ET or LBRs during assisted reproductive technology.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2022 Journal of Human Reproductive Sciences.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje